Sensorion (STU:RFM) Total Operating Expense: €30.75 Mil (TTM As of Dec. 2025)


STU:RFM Sensorion SA STU:RFM
37 GF Score
Price €0.26
GF Value €0.43
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Sensorion Total Operating Expense?

Sensorion STU:RFM +2.15% 37 Total Operating Expense is €30.75 Mil as of Dec. 2025. GuruFocus rates STU:RFM with a GF Score™ of 37/100 and a GF Value™ of €0.43 (Possible Value Trap). The stock has 1 warning sign investors should review.

Sensorion's Total Operating Expense for the six months ended in Dec. 2025 was €13.54 Mil. Sensorion's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was €30.75 Mil.

Sensorion Total Operating Expense Related Terms

Sensorion Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Sensorion's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sensorion Total Operating Expense Chart

Sensorion Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.33 23.24 22.31 28.40 30.75

Sensorion Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.00 15.32 13.09 17.21 13.54
STU:RFM
37GF Score
Sensorion SA STU:RFM
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sensorion Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €30.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €30.75 Mil mean?
Sensorion (STU:RFM) has a Total Operating Expense of €30.75 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Sensorion and its competitors.
Is Sensorion's Total Operating Expense too high?
Sensorion's current Total Operating Expense is €30.75 Mil. Overall, Sensorion has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sensorion's Total Operating Expense compare to VRTX and REGN?
Sensorion's Total Operating Expense of €30.75 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Sensorion and its competitors. Sensorion's current Total Operating Expense is €30.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sensorion stock overvalued right now?
Based on GuruFocus' analysis, Sensorion (STU:RFM) is currently considered Possible Value Trap. The stock's GF Value™ is €0.43, compared to a current price of €0.26 — trading 39.2% below its estimated fair value. The current Total Operating Expense is €30.75 Mil. Sensorion's overall GF Score™ is 37/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Sensorion (STU:RFM), the current Total Operating Expense is €30.75 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sensorion (STU:RFM) Overvalued in 2026?

Based on GuruFocus' analysis, Sensorion stock appears to be undervalued. The current stock price of €0.26 is trading 39.2% below its estimated GF Value™ of €0.43. GuruFocus considers Sensorion to be Possible Value Trap.

Key valuation signals for STU:RFM:

  • Total Operating Expense: €30.75 Mil
  • GF Value™: €0.43 vs. price of €0.26 (39.2% below fair value)
  • GF Score™: 37/100 with 1 warning sign

No single metric tells the full story. See the STU:RFM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sensorion Business Description

Other Exchanges ALSEN:France
Address 375, rue du Professeur Joseph Blayac, Montpellier, FRA, 34080
Sensorion SA is a France-based clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent hearing loss disorders. The SENS501 (OTOF-GT) targets deafness caused by mutations of the gene encoding for otoferlin and is currently developed in a Phase 1/2 clinical study, and GJB2-GT targets hearing loss related to mutations in GJB2 gene to potentially address important hearing loss segments in adults and children. The Company is also working on the identification of biomarkers to improve diagnosis of these underserved illnesses. The company's pipeline programs are OTOF-GT (SENS-501), GJB2-GT, GJB2-GT, GJB2-GT, TREAT AND PREVENT, SENS-401 COCHLEAR, SENS-401 CIO, and SENS-401 SSNHL.
37GF Score

Get the complete analysis for STU:RFM

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.26
Price
€0.43
GF Value